BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1717556)

  • 1. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD; Lechler RI
    J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
    Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
    J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
    McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines.
    Lechler RI; Bal V; Rothbard JB; Germain RN; Sekaly R; Long EO; Lamb J
    J Immunol; 1988 Nov; 141(9):3003-9. PubMed ID: 2459238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression of hybrid murine/human MHC class II beta alpha dimers. Key influence of residues in the amino-terminal portion of the beta 1 domain.
    Lechler RI; Sant AJ; Braunstein NS; Sekaly R; Long E; Germain RN
    J Immunol; 1990 Jan; 144(1):329-33. PubMed ID: 2404065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of human anti-mouse H-2E xenorecognition: T cell receptor bias and impaired CD4 interaction contribute to weak xenoresponses.
    Ramesh P; Barber L; Batchelor JR; Lechler RI
    Int Immunol; 1992 Aug; 4(8):935-43. PubMed ID: 1358190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
    Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
    J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
    Batten P; Heaton T; Fuller-Espie S; Lechler RI
    J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D.
    Fairchild RL; Kubo RT; Moorhead JW
    J Immunol; 1990 Oct; 145(7):2001-9. PubMed ID: 1697873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of class II MHC allelic control of T cell responses.
    Racioppi L; Ronchese F; Schwartz RH; Germain RN
    J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I; Clark S; Henderson LA; Hood L; McMillan M; Forman J
    J Immunol; 1985 Sep; 135(3):2160-6. PubMed ID: 2410513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.